Inventor · disambiguated record
Thomas Albert Engler
Also filed as: ENGLER THOMAS ALBERT
10 granted patents·1 pending application·64 citations·filing 2001–2014
88Inventor score
Technology areasA61P
Top patents by PatentIndex Score
11 records- 0187US7511056B2TGF-β inhibitorsLILLY CO ELI·Filed 2005·Granted Mar 31, 2009·12 cites·4 claims
- 0283US8022065B2Purine derivatives as kinase inhibitorsLILLY CO ELI·Filed 2008·Granted Sep 20, 2011·4 cites·10 claims
- 0381US7491716B2Purine derivatives as kinase inhibitorsLILLY CO ELI·Filed 2003·Granted Feb 17, 2009·12 cites·3 claims
- 0477US7405299B2Compounds as pharmaceutical agentsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·15 cites·1 claims
- 0575US8058425B2Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Granted Nov 15, 2011·5 cites·8 claims
- 0670US8318713B2Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepineCHEDID MARCIO·Filed 2008·Granted Nov 27, 2012·1 cites·5 claims
- 0769US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 0869US7109229B2Methods and compounds for treating proliferative diseasesLILLY CO ELI·Filed 2001·Granted Sep 19, 2006·7 cites·8 claims
- 0968US8648063B2Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepineLILLY CO ELI·Filed 2012·Granted Feb 11, 2014·1 cites·2 claims
- 1062US9624218B2Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitorsLILLY CO ELI·Filed 2014·Granted Apr 18, 2017·1 cites·9 claims
- 1147US2011294792A1Purine derivatives as kinase inhibitorsENGLER THOMAS ALBERT·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Albert Engler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →